Summit Securities Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $351K | Buy |
+866
| New | +$351K | 0.07% | 84 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 700 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 710 |
|
|
2023
Q3 | – | Sell |
-504
| Closed | -$263K | – | 833 |
|
|
2023
Q2 | $263K | Sell |
504
-266
| -35% | -$139K | 0.03% | 107 |
|
|
2023
Q1 | $444K | Buy |
770
+370
| +93% | +$213K | 0.04% | 64 |
|
|
2022
Q4 | $220K | Buy |
400
+157
| +65% | +$86.4K | 0.01% | 294 |
|
|
2022
Q3 | $123K | Sell |
243
-573
| -70% | -$290K | 0.01% | 326 |
|
|
2022
Q2 | $443K | Buy |
816
+655
| +407% | +$356K | 0.06% | 109 |
|
|
2022
Q1 | $95K | Buy |
+161
| New | +$95K | 0.01% | 337 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 522 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 481 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 483 |
|
|
2015
Q3 | – | Sell |
-378
| Closed | -$49K | – | 465 |
|
|
2015
Q2 | $49K | Buy |
+378
| New | +$49K | 0.02% | 201 |
|